Equities analysts expect that Cognex Co. (NASDAQ:CGNX) will post earnings per share (EPS) of $0.47 for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Cognex’s earnings, with the lowest EPS estimate coming in at $0.44 and the highest estimate coming in at $0.53. Cognex posted earnings per share of $0.49 in the same quarter last year, which suggests a negative year over year growth rate of 4.1%. The company is scheduled to issue its next earnings results on Wednesday, October 27th.
On average, analysts expect that Cognex will report full year earnings of $1.58 per share for the current year, with EPS estimates ranging from $1.53 to $1.62. For the next year, analysts expect that the firm will report earnings of $1.93 per share, with EPS estimates ranging from $1.70 to $2.20. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that follow Cognex.
Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Thursday, August 5th. The scientific and technical instruments company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.38 by $0.05. Cognex had a return on equity of 21.92% and a net margin of 30.96%. The business had revenue of $269.16 million during the quarter, compared to analyst estimates of $263.11 million.
In other Cognex news, Director Patrick Alias sold 17,500 shares of the firm’s stock in a transaction dated Tuesday, August 24th. The stock was sold at an average price of $87.19, for a total transaction of $1,525,825.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Anthony Sun sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, September 8th. The stock was sold at an average price of $86.41, for a total value of $2,592,300.00. Following the transaction, the director now directly owns 337,262 shares in the company, valued at approximately $29,142,809.42. The disclosure for this sale can be found here. 3.90% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in CGNX. Total Clarity Wealth Management Inc. purchased a new position in shares of Cognex during the first quarter worth about $25,000. Massmutual Trust Co. FSB ADV grew its holdings in shares of Cognex by 155.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 306 shares of the scientific and technical instruments company’s stock worth $26,000 after buying an additional 186 shares during the last quarter. Wealthcare Advisory Partners LLC purchased a new position in shares of Cognex during the first quarter worth about $28,000. Strategic Blueprint LLC purchased a new position in shares of Cognex during the second quarter worth about $37,000. Finally, Newfound Research LLC purchased a new position in shares of Cognex during the second quarter worth about $42,000. 88.25% of the stock is currently owned by hedge funds and other institutional investors.
CGNX opened at $90.95 on Tuesday. Cognex has a 52 week low of $58.82 and a 52 week high of $101.82. The business has a fifty day simple moving average of $86.32 and a 200-day simple moving average of $82.83. The firm has a market cap of $16.07 billion, a P/E ratio of 53.50 and a beta of 1.65.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 3rd. Shareholders of record on Friday, August 20th were paid a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date of this dividend was Thursday, August 19th. Cognex’s dividend payout ratio is presently 24.00%.
Cognex Company Profile
Cognex Corp. engages in the provision of machine vision products that capture and analyze visual information in order to automate tasks in processes, where vision is required. The company was founded by Robert J. Shillman, William Silver and Marilyn Matz in 1981 and is headquartered in Natick, MA.
Recommended Story: Trading signals using Bollinger bands
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.